Similarly, MK-2206 was shown to significantly reduce tumor growth in a PTEN-deficient prostate cancer model text, mTOR activity was not suppressed suggesting that mTOR signaling is regulated independently of AKT in this setting [206]. This evidence concerns the gene PTEN and prostate cancer.